Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Agnosia × Diathermy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hyperthermia 8 Prostatic Neoplasms 4 Uterine Cervical Neoplasms 2 Sarcoma 2 Melanoma 2 Head and Neck Neoplasms 2 Carcinoma, Hepatocellular 2 Urinary Bladder Neoplasms 1 Salivary Gland Adenoma, Pleomorphic 1 Rectal Neoplasms 1 Prehypertension 1 Prediabetic State 1 Polycystic Ovary Syndrome 1 Pelvic Pain 1 Ovarian Neoplasms 1 Obesity 1 Neoplasms, Radiation-Induced 1 Neoplasms 1 Neoplasm Metastasis 1 Metabolic Syndrome 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1 Kidney Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1 Agnosia 1 Acute Pain 1

Interventions

Anesthesia, General 5 Dexmedetomidine 4 Bupivacaine 4 Anesthesia, Local 4 Acupuncture Therapy 4 parecoxib 2 Transcutaneous Electric Nerve Stimulation 2 Saline Solution 2 Ropivacaine 2 Radiofrequency Ablation 2 Pregabalin 2 Morphine 2 Fentanyl 2 Ethanol 2 Dental Occlusion 2 Control Groups 2 Anesthetics, Local 2 Anesthesia, Conduction 2 Analgesics, Opioid 2 loxoprofen 1 engage 8200 1 Yoga 1 Uterine Myomectomy 1 Transcranial Direct Current Stimulation 1 Tramadol 1 Touch 1 Telemedicine 1 Surgical Instruments 1 Standard of Care 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04778631 2025-11-20

PERISAFE

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

Hyperthermia, Agnosia, Neoplasm Metastasis, Pelvic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡